Your browser does not support JavaScript!
Logo Labiotech.eu

Labiotech.eu

Informations juridiques

SIREN / SIRET - DE Labiotech

Toutes les actualités :

Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 semaines

Biosimilars: a vital remedy for Europe’s healthcare challenges

Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future. The post Biosimilars: a vital remedy for Europe’s healthcare challenges...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 semaines

iGEM Jamboree: leap into the synthetic biology future

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology. The post iGEM Jamboree: leap into the synthetic biology future appeared...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 semaines

New cancer cell discovery sheds light on childhood blood cancer  

The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research. The post New cancer cell discovery sheds light on childhood blood cancer...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 semaines

BIO-Europe partnering: Australian biotech companies share their experiences

Australian biotechs share lessons from BIO-Europe on building global partnerships and driving growth beyond their domestic market. The post BIO-Europe partnering: Australian biotech companies share...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 10/11/2025

Next?generation UTI diagnostics: delivering results in just 35 minutes

Llusern’s Lodestar DX aims to improve urinary tract infection diagnostics. It has created a test that detects pathogens in just 35 minutes, no lab required. The post Next?generation UTI diagnostics:...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 10/11/2025

Top biotech deals in October 2025 

October saw a wave of M&As and biotech deals in various therapeutic fields, but particularly for therapies addressing autoimmune conditions. The post Top biotech deals in October 2025 appeared...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 06/11/2025

Novo Nordisk’s pipeline plan: How the pharma giant is refocusing amid major restructuring

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and obesity. The post Novo Nordisk’s pipeline plan: How the pharma giant is...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 05/11/2025

Rethinking protein production: Why Pichia pastoris is gaining ground in biotech

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems. The post Rethinking protein production: Why Pichia...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 05/11/2025

The biggest biotech funding rounds in October 2025

The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025. The post The biggest biotech funding rounds in October 2025...

www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Le 04/11/2025

AAVantgarde closes $141 million series B round to tackle inherited eye diseases 

Today AAvantgarde closes a $141 million series B round to advance its inherited eye diseases pipeline; find out more about its approach! The post AAVantgarde closes $141 million series B round to...

www.labiotech.eu
Charger plus d'actualités

Activités de l'entreprise

Adresse
Berlin Berlin DE Allemagne
Equipes
Je travaille dans cette entreprise